Never miss out on the latest news!
Sign up to the Thrombosis Adviser newsletter.
Vascular disease and its many manifestations, including coronary artery disease (CAD) and peripheral artery disease (PAD), have a major impact on the lives of millions of patients and those around them. Major advances in surgical and medical management strategies have helped healthcare professionals reduce its impact. However, despite these advances, the residual risk of major adverse cardiac events remains high. Research into innovative strategies to address this residual risk is ongoing. Whether it is through the use of different combinations of antithrombotic drugs, reducing lipid levels or other disease mediators, the area of Vascular Protection is exciting and continues to evolve.
Vascular Adviser is developed in collaboration with a Steering Committee who are experts in the field of Vascular Protection.
The Steering Committee is dedicated to fostering awareness and understanding about new approaches in the prevention, diagnosis, and treatment of vascular diseases.
The sponsor provides financial support for the website, and reviews content to ensure accuracy of information in compliance with established pharmaceutical codes of practice.